Lv7
3290 积分 2023-10-01 加入
Clinical Outcomes from the Pooled Safety Analysis of CD19 Nex-T™ (BMS-986353), a Chimeric Antigen Receptor (CAR) T cell Therapy Manufactured Using a Next-Generation Process, in Severe Refractory Autoimmune Diseases: Results from Phase 1 Breakfree Studies
4小时前
待确认
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
13天前
已完结
Stiff-person syndrome and related disorders — diagnosis, mechanisms and therapies
3个月前
已完结
Clinical application of base editing for treating β-thalassaemia
4个月前
已完结
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
4个月前
已完结
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia
4个月前
已完结
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
7个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
7个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
7个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
7个月前
已完结
皖公网安备34019202002308
